HomeIndustriesHealthcare"If it Isn't A.I., It's Weight Loss": Eli Lilly (LLY) Rallies on Earnings
"If it Isn't A.I., It's Weight Loss": Eli Lilly (LLY) Rallies on Earnings
James Demmert joins Oliver Renick and Tom White to discuss Eli Lilly's (LLY) 2Q earnings beat, the impact of GLP-1 drugs and the outlook for the health care sector.